semaglutide peak time U.S. FDA panel to review 7 peptides amid growing popularity GLP-1s are changing more than

GLP-1 drugs offer a powerful tool for individuals struggling with obesity who may not be candidates for surgery or who have not achieved success with lifestyle modifications alone

Kennedy Jr., the FDA announced it will meet this summer to consider easing restrictions on more than half a dozen peptides including BPC-157, an injury-repair drug popular with influencers and athletes

Copper peptides are generally not recommended during pregnancy or breastfeeding due to insufficient research, not known harm

How to Maintain Weight After a GLP-1 Medication By Lizzie Streit, MS, RDN, LD GLP-1 receptor agonists, such as Ozempic and Wegovy, have helped thousands of people lose weight and manage type 2 diabetes, heart disease, and other conditions

Complex relationship between growth hormone and sleep in children: insights, discrepancies, and implications